Wall Street Journal, Who's News
May 5, 2007

Solace Pharmaceuticals

(Boston) -- Eliot Forster was named chief executive with this developer of therapeutics for chronic pain. Dr. Forster, 41, most recently served as head of development for Europe and Asia with Pfizer Inc. He succeeds Daphne Zohar. Ms. Zohar, 36, is the founding and managing partner of PureTech Ventures LLC, which helped launch Solace.

http://blogs.wsj.com/whosnews/2007/05/07/solace-pharmaceuticals/